Skip to main content

Together we are beating cancer

Donate now

Treatment

Showing 12 out of 1231 results
ASCO 2015
  • Science & Technology
  • Health & Medicine

ASCO 2015 round-up: immunotherapy continues to come of age

We take a look back at the excitement from - and add a few important caveats to - the research from this year's big US cancer conference. We take a look back at the excitement from - and add a few important caveats to - the research from this year's big US cancer conference.

by Alan Worsley | Analysis | 5 June 2015

5 June 2015

Drugs

In light of a preliminary 'no' from NICE over olaparib for ovarian cancer, we hear from one of our experts whose work led to the drug's development In light of a preliminary 'no' from NICE over olaparib for ovarian cancer, we hear from one of our experts whose work led to the drug's development

by Cancer Research UK | Analysis | 1 June 2015

1 June 2015

Cancer Research UK scientists have discovered how giving a class of drugs called AKT inhibitors in combination with radiotherapy might boost its effectiveness Cancer Research UK scientists have discovered how giving a class of drugs called AKT inhibitors in combination with radiotherapy might boost its effectiveness

by Cancer Research UK | News | 1 June 2015

1 June 2015

Dendritic cells

A new immunotherapy drug has shown continued promise fortreating various types of cancer in a series of trials presented at a US conference. A new immunotherapy drug has shown continued promise fortreating various types of cancer in a series of trials presented at a US conference.

by In collaboration with PA Media Group | News | 1 June 2015

1 June 2015

For International Clinical Trials Day 2015 we look at how trials have changed - from the first recorded trial to today's modern cancer clinical trials. For International Clinical Trials Day 2015 we look at how trials have changed - from the first recorded trial to today's modern cancer clinical trials.

by Aine McCarthy | Analysis | 20 May 2015

20 May 2015

Hoax email

Hoax emails about cancer risks and treatments are misleading and confusing, so don't pass them on. Here are the facts behind the claims. Hoax emails about cancer risks and treatments are misleading and confusing, so don't pass them on. Here are the facts behind the claims.

by Kat Arney | Analysis | 8 May 2015

8 May 2015

At Wired Health 2015, Professor Sonia Trigueros told the audience about her ambitious project to design nano-sized drugs that target cancer cells. At Wired Health 2015, Professor Sonia Trigueros told the audience about her ambitious project to design nano-sized drugs that target cancer cells.

by Misha Gajewski | Analysis | 5 May 2015

5 May 2015

Liquid nitrogen science
  • Science & Technology
  • Health & Medicine

Pint of Science 2015: from cows to cancer clinical trials

Fancy hearing about the latest developments in cancer research? Well some of our scientists might be gathering in a venue near you to tell all. Fancy hearing about the latest developments in cancer research? Well some of our scientists might be gathering in a venue near you to tell all.

by Nick Peel | Analysis | 1 May 2015

1 May 2015

A man gardening

Dr Abi Fisher from our UCL Health Behaviour Research Centre blogs about her recent paper looking at physical activity rates in people with bowel cancer Dr Abi Fisher from our UCL Health Behaviour Research Centre blogs about her recent paper looking at physical activity rates in people with bowel cancer

by Dr Abi Fisher | Analysis | 29 April 2015

29 April 2015